» Articles » PMID: 33784507

Nuclear Receptor Coactivator 4-mediated Ferritinophagy Drives Proliferation of Dental Pulp Stem Cells in Hypoxia

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2021 Mar 30
PMID 33784507
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy has been implicated in the ferroptosis in cancer cells and hematopoiesis in the bone marrow. However, the role of iron metabolism, especially NCOA4-mediated degradation of ferritin, has not been explored in the proliferation of mesenchymal stem cells. The present study was designed to explore the role of NCOA4-mediated ferritinophagy in hypoxia-treated dental pulp stem cells (DPSCs). Hypoxia treatment increased ROS generation, boosted cytosolic labile iron pool, increased expression of transferrin receptor 1 and NCOA4. Moreover, colocalization of LC3B with NCOA4 and ferritin was observed in hypoxia-treated DPSCs, indicating the development of ferritinophagy. Hypoxia promoted the proliferation of DPSCs, but not ferroptosis, under normal serum supplement and serum deprivation. NCOA4 knock-down reduced ferritin degradation and inhibited proliferation of DPSCs under hypoxia. Furthermore, the activation of hypoxia inducible factor 1α and p38 mitogen-activated protein kinase signaling pathway was involved in the upregulation of NCOA4 in hypoxia. Therefore, our present study suggested that NCOA4-mediated ferritinophagy promoted the level of labile iron pool, leading to enhanced iron availability and elevated cell proliferation of DPSCs. Our present study uncovered a physiological role of ferritinophagy in the proliferation and growth of mesenchymal stem cells under hypoxia.

Citing Articles

Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus.

Dai L, Wang Q Stem Cell Res Ther. 2025; 16(1):47.

PMID: 39901210 PMC: 11792594. DOI: 10.1186/s13287-025-04188-7.


Targeting ferroptosis to enhance the efficacy of mesenchymal stem cell-based treatments for intervertebral disc degeneration.

Xu Y, Xu X, Chai R, Wu X Int J Biol Sci. 2025; 21(3):1222-1241.

PMID: 39897051 PMC: 11781166. DOI: 10.7150/ijbs.107021.


Inhibition of ZDHHC16 promoted osteogenic differentiation and reduced ferroptosis of dental pulp stem cells by CREB.

Liu W, Yu W, Zhou L, Ling D, Xu Y, He F BMC Oral Health. 2024; 24(1):388.

PMID: 38532349 PMC: 10964552. DOI: 10.1186/s12903-024-04107-x.


Influence of hypoxia on retinal progenitor and ganglion cells in human induced pluripotent stem cell-derived retinal organoids.

Du J, Gao L, Wang T, Ye Z, Li H, Li W Int J Ophthalmol. 2023; 16(10):1574-1581.

PMID: 37854379 PMC: 10559029. DOI: 10.18240/ijo.2023.10.03.


Ferroptosis open a new door for colorectal cancer treatment.

Liang H, He X, Tong Y, Bai N, Pu Y, Han K Front Oncol. 2023; 13:1059520.

PMID: 37007121 PMC: 10061081. DOI: 10.3389/fonc.2023.1059520.